Quarterly report pursuant to Section 13 or 15(d)

CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED

v3.22.2.2
CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED - USD ($)
 9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Cash Flows for Operating Activities:    
Net loss $ (6,104,498) $ (5,490,845)
Adjustments to reconcile net loss to net cash used by operating activities:    
Non cash lease expense 58,159 16,257
Gain on forgiveness of debt 0 (121,700)
Amortization of deferred R&D obligations participation agreements (702,045) (350,099)
Employee and director equity-based compensation expense 1,586,534 1,466,188
Changes in assets and liabilities:    
Prepaid expenses (284,487) (102,132)
Accounts payable (47,352) (830,812)
Lease liabilities (32,238) (19,886)
Security deposits (29,058) 0
Advanced payments for R&D obligations - participation agreements 0 85,303
Accrued liabilities (100,605) 445,919
Net cash (used in) operating activities (5,655,590) (4,901,809)
Cash Flows from Investing Activities:    
Net cash from by investing activities 0 0
Cash Flow from Financing Activities:    
Proceeds of notes payable, other 628,600 190,500
Payments of notes payable, other (488,911) (190,500)
Proceeds from public sale of common stock and warrants 0 14,552,739
Proceeds from exercise of registered warrants 0 1,091,767
Expenses related to the public offering 0 (1,697,828)
Proceeds from sale of common stock warrants - participation agreements 0 55,697
Proceeds from sale of common stock - related party 0 50,000
Proceeds from sales of common stock 0 1,514,970
Net cash provided by financing activities 139,689 15,567,345
Increase/(Decrease) in Cash (5,515,901) 10,665,536
Cash at Beginning of Period 8,901,875 137,862
Cash at End of Period 3,385,974 10,803,398
Cash paid during the period for:    
Interest 8,493 3,084
Income Taxes $ 0 $ 0